WallStSmart

Keurig Dr Pepper Inc (KDP)vsNiagen Bioscience, Inc. (NAGE)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Keurig Dr Pepper Inc generates 15464% more annual revenue ($20.09B vs $129.08M). NAGE leads profitability with a 12.4% profit margin vs 7.1%. NAGE trades at a lower P/E of 16.0x. KDP earns a higher WallStSmart Score of 61/100 (C+).

KDP

Buy

61

out of 100

Grade: C+

Growth: 6.0Profit: 5.0Value: 6.7Quality: 4.0
Piotroski: 5/9Altman Z: 1.09

NAGE

Hold

40

out of 100

Grade: D

Growth: 4.7Profit: 6.0Value: 6.0Quality: 8.5
Piotroski: 4/9Altman Z: 2.02
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KDPUndervalued (+63.1%)

Margin of Safety

+63.1%

Fair Value

$81.12

Current Price

$31.39

$49.73 discount

UndervaluedFair: $81.12Overvalued

Intrinsic value data unavailable for NAGE.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KDP2 strengths · Avg: 9.0/10
Revenue GrowthGrowth
75.6%10/10

Revenue surging 75.6% year-over-year

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

NAGE4 strengths · Avg: 8.8/10
Debt/EquityHealth
0.0310/10

Conservative balance sheet, low leverage

Return on EquityProfitability
22.6%9/10

Every $100 of equity generates 23 in profit

P/E RatioValuation
16.0x8/10

Attractively priced relative to earnings

Price/BookValuation
2.9x8/10

Reasonable price relative to book value

Areas to Watch

KDP4 concerns · Avg: 3.3/10
P/E RatioValuation
32.9x4/10

Premium valuation, high expectations priced in

Return on EquityProfitability
5.7%3/10

ROE of 5.7% — below average capital efficiency

Profit MarginProfitability
7.1%3/10

7.1% margin — thin

Debt/EquityHealth
1.373/10

Elevated debt levels

NAGE4 concerns · Avg: 2.5/10
Market CapQuality
$240.15M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
2.4%3/10

Operating margin of 2.4%

Revenue GrowthGrowth
-4.3%2/10

Revenue declined 4.3%

EPS GrowthGrowth
-75.0%2/10

Earnings declined 75.0%

Comparative Analysis Report

WallStSmart Research

Bull Case : KDP

The strongest argument for KDP centers on Revenue Growth, Price/Book. Revenue growth of 75.6% demonstrates continued momentum. PEG of 1.01 suggests the stock is reasonably priced for its growth.

Bull Case : NAGE

The strongest argument for NAGE centers on Debt/Equity, Return on Equity, P/E Ratio.

Bear Case : KDP

The primary concerns for KDP are P/E Ratio, Return on Equity, Profit Margin.

Bear Case : NAGE

The primary concerns for NAGE are Market Cap, Operating Margin, Revenue Growth.

Key Dynamics to Monitor

KDP profiles as a hypergrowth stock while NAGE is a declining play — different risk/reward profiles.

NAGE carries more volatility with a beta of 2.09 — expect wider price swings.

KDP is growing revenue faster at 75.6% — sustainability is the question.

KDP generates stronger free cash flow (714M), providing more financial flexibility.

Bottom Line

KDP scores higher overall (61/100 vs 40/100) and 75.6% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Keurig Dr Pepper Inc

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

Keurig Dr Pepper Inc. is a beverage company in the United States and internationally. The company is headquartered in Burlington, Massachusetts.

Niagen Bioscience, Inc.

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

Niagen Bioscience, Inc. is a bioscience company engages in developing healthy aging products. The company is headquartered in Los Angeles, California.

Want to dig deeper into these stocks?